What is AI and healthcare?

At a glance

• By end of May 2025 the FDA had cleared 1,247 AI-enabled medical devices, with 956 (about three-quarters) in radiology/imaging.^[1]
• 57% of healthcare organizations say cutting administrative burden is AI’s biggest opportunity; 68% of physicians report rising AI use for documentation.^[2]
• 85% of healthcare organizations had adopted or explored generative AI by end of 2024, and 45% saw measurable return within 12 months.^[2]
• The global AI-in-healthcare market was roughly $37 billion in 2025 and is forecast to grow over 35% per year.^[3]

Where it actually shows up

Three buckets matter most. Imaging: AI flags possible tumors or strokes on scans for a radiologist to confirm.^[1] Documentation: AI scribes listen to a visit and draft the note.^[4] Back office: AI handles scheduling, claims, prior authorization, and billing, where US clinicians spend nearly two hours of paperwork per hour of care.^[4]

What it means for a business

Most near-term value is administrative, not diagnostic.^[2] AI does not replace clinicians; it drafts and flags while a human decides and signs off. Returns can arrive within a year, but FDA rules, accuracy limits, and patient-privacy laws mean tools need vetting before they touch care or records.^[1]

Bottom line

For most healthcare businesses, AI’s clearest payoff today is automating documentation and back-office paperwork, while imaging and diagnostic tools assist clinicians under FDA oversight rather than replacing them.